(Procalcitonin is a predictor of disseminated intravascular coagulation in patients with fatal COVID-19)
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.24, sa.22, ss.11953-11959, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 24 Sayı: 22
- Basım Tarihi: 2020
- Doi Numarası: 10.26355/eurrev_202011_23856
- Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Sayfa Sayıları: ss.11953-11959
- Anahtar Kelimeler: COVID-19, Disseminated intravascular coagulopathy, Procalcitonin, D-dimer, Prothrombin time, CORONAVIRUS DISEASE 2019, CLINICAL CHARACTERISTICS, BIOMARKERS, WUHAN, PCT
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
OBJECTIVE: The coagulopathies that present with COVID-19 are thrombotic microangiopathy and disseminated intravascular coagulopathy (DIC). Procalcitonin (PCT) levels have been shown to be significantly increased in COVID-19 patients in comparison with healthy subjects/asymptomatic coronavirus-positive patients. In this report, our aim was to assess the associations of the PCT level with DIC and the severity of COVID-19 infection.